Qube Research & Technologies (QRT)
CNTB

Qube Research & Technologies (QRT)’s Connect Biopharma Holdings CNTB Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,449
Closed -$29.5K – 3603
2025
Q4 		$29.5K Buy
+10,449
New +$22.3K ﹤0.01% 3342
2024
Q3 		– Sell
-46
Closed -$70 – 3422
2024
Q2 		$70 Hold
46
– – ﹤0.01% 3463
2024
Q1 		$80 Hold
46
– – ﹤0.01% 4192
2023
Q4 		$54 Hold
46
– – ﹤0.01% 4065
2023
Q3 		$36 Buy
+46
New +$42 ﹤0.01% 3841

Other funds holding CNTB

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
DMKJ
David M. Knott Jr $168M AUM 60.36% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CNTB Position: Q1 2026 in Review

Qube Research & Technologies (QRT) sold out of Connect Biopharma Holdings (CNTB) in Q1 2026, closing a stake of 10,449 shares — an estimated $29.5K sold.

Qube Research & Technologies (QRT) first reported a position in CNTB in Q3 2023 and held it in 5 quarters. The position peaked at $29.5K in Q4 2025. 41 funds tracked by Wall St. Rank hold CNTB as of Q1 2026.

  • Qube Research & Technologies (QRT) reported no remaining Connect Biopharma Holdings position as of Q1 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 10,449 Connect Biopharma Holdings shares in Q1 2026, an estimated $29.5K.
  • Qube Research & Technologies (QRT) first reported a position in Connect Biopharma Holdings in Q3 2023 and held it in 5 quarters.
  • Qube Research & Technologies (QRT)'s Connect Biopharma Holdings position peaked at $29.5K in Q4 2025.
  • 41 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.